自身免疫性肝炎患者外周血CD8+T细胞PD-1表达水平变化

doi:10.3969/j.issn.1672-5069.2017.03.025

Abstract

Rui Zhilian. Programmed cell death-1 and programmed cell death-1 receptor on peripheral blood CD8⁺T lymphocytes in patients with autoimmune hepatitis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 352-353.

References

[1] 张宏宇,张晓刚,何梅芳,等. PD-1/PD-L1在自身免疫性肝炎患者外周血T 淋巴细胞中的表达及意义.广东医学,2016,37(1):101-103.
[2] Than NN,Wiegard C,Weiler-Normann C,et al.Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on tacrolimus therapy.Scand J Gastroenterol,2016,51(3):329-336.
[3] Jiménez-Rivera C,Ling SC,Ahmed N,et al.Incidence and characteristics of autoimmune hepatitis. Pediatrics,2015,136(5): 1237-1248.
[4] 艾国,肖芳,汪鹏,等. 自身免疫性肝炎患者外周血CD8+T淋巴细胞PD-1表达及意义. 实用肝脏病杂志,2013,16(4):320-322.
[5] 任健,柯宗明. 自身免疫性肝炎患者PD-1及SIRPα表达及意义. 海南医学院学报,2014,20(9):1184-1186.
[6] Tabll A,Abbas AT,El-Kafrawy S,et al.Monoclonal antibodies:principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus. World J Hepatol,2015,7(22):2369-2383.
[7] DeFilippis EM,Kumar S. Clinical presentation and outcomes of autoimmune hepatitis in inflammatory bowel disease. Dig Dis Sci,2015,60(10):2873-2880.
[8] 范晓飞,林睿,罗莉丽,等. 自身免疫性肝炎合并肝外自身免疫疾病患者的临床特点观察. 山东医药,2014,15(40):75-77.
[9] 赵素贤,张玉果,谭普芳,等. 药物诱导的自身免疫性肝炎与药物性肝损伤的临床特征对照研究.中华肝脏病杂志,2016,24(4):302-306.
[10] De Martin E,Coilly A,Ichai P,et al.The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable. J Hepatol,2015,63(4):1041-1042.
[11] Muratori P,Fabbri A,Lalanne C,et al.Autoimmune liver disease and concomitant extrahepatic autoimmune disease. Eur J Gastroenterol Hepatol,2015,27(10):1175-1179.
[12] 胡晓蕾,赵志钢,骆方军,等. 浙江省丽水市强直性脊柱炎患者外周血CD4+T淋巴细胞和CD8+T淋巴细胞程序性死亡因子1的表达及意义研究.中国全科医学,2016,13(6):678-682.
[13] 夏红,周智,杨玉霞,等. 乙型肝炎患者恩替卡韦抗病毒治疗后外周血T淋巴细胞PD-1的表达及其与HBeAg血清学的关系.海南医学院学报,2016,22(7):655-657.
[14] Yeoman AD,Kotha S,Heneghan MA.Reply to“the role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable”. J Hepatol,2015,63(4):1043.
[15] Lian F,Wang Y,Xiao Y,et al.Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis. Mol Med Rep,2015,12(4):5821-5827.
[16] 周俊英,周东方,李俊卿,等. 青少年慢性乙型肝炎患者乙型肝炎病毒特异性CD8+T淋巴细胞程序性死亡分子-1的表达. 中华肝脏病杂志,2013,21(1):27-32.

Programmed cell death-1 and programmed cell death-1 receptor on peripheral blood CD8⁺T lymphocytes in patients with autoimmune hepatitis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Wang Daowei, Fang Jian, Fan Ling.. Implication of serum IL-21 and chemokine levels in patients with autoimmune hepatitis [J]. Journal of Practical Hepatology, 2019, 22(6): 844-847.
[2]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.
[3]	Zhou Yanyi, Yang Can. Efficacy of tripterygium glycosides combined with magnesium isoglycyrrhizinate in treatment of patients with autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 365-368.
[4]	Peng Xiaoyan, Xu Lijuan, Liu Peng, Qi Shuangbao, Sun Yiming. Changes of serum adenosine deaminase levels in patients with autoimmune hepatitis and its correlation to hepatic activity index and response to steroid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 200-203.
[5]	Lin Lan, Shen Min, Ruan Jianwen.. Expression of programmed death receptor 1 in liver tissue of patients with autoimmune hepatitis and its clinical implications [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 204-207.
[6]	Xia Geng, Qi Fei, Yang Jinhui.. Predisposing factors to autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 983-986.
[7]	Liu Liangyi, Su Dongyuan. Comparison of clinical and liver pathological features of patients with drug-induced liver injury and autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 463-464.
[8]	Lei Jing. Observation of silybin and diammonium glycyrrhizinate in the treatment of patients with autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 108-109.
[9]	Shang Rui, Wu Jun. Effect of tripterygium glycosides and azathioprine combined with diammonium glycyrrhizinate in the treatment of patients with autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 290-293.
[10]	Liu Lulu, Qiao Kuan, Wang Bingyuan.. Clinical examination characteristics of elderly patients with autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 46-50.
[11]	Chai Yanyun, Li Jianguo. Autoimmune hepatitis in child: one case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 114-114.
[12]	Ren Fangyuan, Li Xiaodan.. Efficacy of western medicine and Chinese traditional medicine in treatment of patients with type I autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 549-552.
[13]	Ai Yuemei,Yan Yujuan,Xing Yiping. Autoimmune liver diseases: the mist really clears? [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 360-364.
[14]	Liu Lulu， Wang Bingyuan.. Elderly autoimmune hepatitis： Pathogenisis，diagnosis and treatment [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 578-580.
[15]	Jiang Xiang, Wang Qixia, Ma Xiong. What's going on in dignosis and treatment of patients with autoimmune liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 15-19.

Programmed cell death-1 and programmed cell death-1 receptor on peripheral blood CD8+T lymphocytes in patients with autoimmune hepatitis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

Programmed cell death-1 and programmed cell death-1 receptor on peripheral blood CD8⁺T lymphocytes in patients with autoimmune hepatitis